Palexia retard 50 mg

Palexia retard 50 mg is a medicine authorised by Swissmedic under authorisation number 62452. The authorisation holder is Grünenthal Pharma AG. The medicinal product code is Synthetic medicines and the dispensing category is A+: Supplied only against a single-use prescription with additional Swissmedic conditions, for example narcotics or medicines with mandatory educational material. First authorisation was granted on 20 November 2013 and the authorisation is valid without a time limit. ATC code N02AX06 places the medicine in the group Analgesics.

  • Dispensing category A+
  • Authorisation number 62452
  • ATC N02AX06
  • Synthetic medicines
Authorisation data
Authorisation number62452
NamePalexia retard 50 mg
Full namePalexia retard 50 mg, Retardtabletten
Authorisation holderGrünenthal Pharma AG
Medicinal product codeSynthetic medicines
Dispensing categoryA+ · Prescription with conditions
ATC codeN02AX06
First authorisation20 November 2013
Authorisation validityunlimited
Strengths
No.NameDispensing categoryAuthorisation date
1Palexia retard 50 mg, RetardtablettenA+20 November 2013
2Palexia retard 100 mg, RetardtablettenA+20 November 2013
3Palexia retard 150 mg, RetardtablettenA+20 November 2013
4Palexia retard 200 mg, RetardtablettenA+20 November 2013
5Palexia retard 250 mg, RetardtablettenA+20 November 2013
6Palexia retard 25 mg, RetardtablettenA+06 April 2016

Scroll the table sideways

Pack sizes
Pack codeQuantityUnitATCIT codeDispensing category
130Tablette(n)N02AX0601.01.3.A+
260Tablette(n)N02AX0601.01.3.A+
330Tablette(n)N02AX0601.01.3.A+
460Tablette(n)N02AX0601.01.3.A+
530Tablette(n)N02AX0601.01.3.A+
660Tablette(n)N02AX0601.01.3.A+
730Tablette(n)N02AX0601.01.3.A+
860Tablette(n)N02AX0601.01.3.A+
930Tablette(n)N02AX0601.01.3.A+
1060Tablette(n)N02AX0601.01.3.A+
1130Tablette(n)N02AX0601.01.3.A+
1260Tablette(n)N02AX0601.01.3.A+

Scroll the table sideways

Medicines in the same ATC group

Other medicines from this authorisation holder

Frequently asked questions

Is Palexia retard 50 mg authorised in Switzerland?

Yes. Palexia retard 50 mg is authorised by Swissmedic under authorisation number 62452, data as of 01 September 2026. The authorisation is valid without a time limit.

Which dispensing category does Palexia retard 50 mg have?

Palexia retard 50 mg is in dispensing category A+. Supplied only against a single-use prescription with additional Swissmedic conditions, for example narcotics or medicines with mandatory educational material.

Who is the authorisation holder of Palexia retard 50 mg?

The authorisation holder is Grünenthal Pharma AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.

Sources

Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.

Authorisation in Switzerland?

About 2 minutes. No obligation.

First, a little about your business.

Your answers stay in this page until you send your enquiry.

What would you like to achieve?

Your project

Where can we reach you?

You can go back to review your answers before sending.

* Required fields
Prefer email? info@swissmedicinesdirectory.com